240 related articles for article (PubMed ID: 19729488)
1. Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion.
Conn EM; Botkjaer KA; Kupriyanova TA; Andreasen PA; Deryugina EI; Quigley JP
Am J Pathol; 2009 Oct; 175(4):1638-52. PubMed ID: 19729488
[TBL] [Abstract][Full Text] [Related]
2. Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells.
Bekes EM; Deryugina EI; Kupriyanova TA; Zajac E; Botkjaer KA; Andreasen PA; Quigley JP
Neoplasia; 2011 Sep; 13(9):806-21. PubMed ID: 21969814
[TBL] [Abstract][Full Text] [Related]
3. Activity-based protein profiling implicates urokinase activation as a key step in human fibrosarcoma intravasation.
Madsen MA; Deryugina EI; Niessen S; Cravatt BF; Quigley JP
J Biol Chem; 2006 Jun; 281(23):15997-6005. PubMed ID: 16611636
[TBL] [Abstract][Full Text] [Related]
4. Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination.
Juncker-Jensen A; Deryugina EI; Rimann I; Zajac E; Kupriyanova TA; Engelholm LH; Quigley JP
Cancer Res; 2013 Jul; 73(14):4196-211. PubMed ID: 23687338
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
Partridge JJ; Madsen MA; Ardi VC; Papagiannakopoulos T; Kupriyanova TA; Quigley JP; Deryugina EI
J Biol Chem; 2007 Dec; 282(49):35964-77. PubMed ID: 17895241
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
7. Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.
Deryugina EI; Zijlstra A; Partridge JJ; Kupriyanova TA; Madsen MA; Papagiannakopoulos T; Quigley JP
Cancer Res; 2005 Dec; 65(23):10959-69. PubMed ID: 16322244
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.
Botkjaer KA; Deryugina EI; Dupont DM; Gårdsvoll H; Bekes EM; Thuesen CK; Chen Z; Ploug M; Quigley JP; Andreasen PA
Mol Cancer Res; 2012 Dec; 10(12):1532-43. PubMed ID: 23038812
[TBL] [Abstract][Full Text] [Related]
9. Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation.
Conn EM; Madsen MA; Cravatt BF; Ruf W; Deryugina EI; Quigley JP
J Biol Chem; 2008 Sep; 283(39):26518-27. PubMed ID: 18658134
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
11. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
Wilson MJ; Sinha AA
Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
[TBL] [Abstract][Full Text] [Related]
12. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M
Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
[TBL] [Abstract][Full Text] [Related]
14. Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice.
Swiercz R; Keck RW; Skrzypczak-Jankun E; Selman SH; Jankun J
Oncol Rep; 2001; 8(3):463-70. PubMed ID: 11295064
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
[TBL] [Abstract][Full Text] [Related]
16. Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.
Zhang L; Zhao ZS; Ru GQ; Ma J
World J Gastroenterol; 2006 Jul; 12(25):3970-6. PubMed ID: 16810742
[TBL] [Abstract][Full Text] [Related]
17. LTBP3 promotes early metastatic events during cancer cell dissemination.
Deryugina EI; Zajac E; Zilberberg L; Muramatsu T; Joshi G; Dabovic B; Rifkin D; Quigley JP
Oncogene; 2018 Apr; 37(14):1815-1829. PubMed ID: 29348457
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin stimulates the secretion of urokinase-type plasminogen activator from prostate cancer cells: its possible implications on tumor cell invasion.
Sabbisetti V; Chigurupati S; Thomas S; Shah G
Int J Cancer; 2006 Jun; 118(11):2694-702. PubMed ID: 16381004
[TBL] [Abstract][Full Text] [Related]
19. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
20. Aspirin inhibits highly invasive prostate cancer cells.
Lloyd FP; Slivova V; Valachovicova T; Sliva D
Int J Oncol; 2003 Nov; 23(5):1277-83. PubMed ID: 14532966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
